, Volume 21, Issue 3, pp 235–246 | Cite as

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids

  • Russell D. Salter
  • David N. Howell
  • Peter Cresswell


Regulation of HLA class I and class II antigen expression was studied in hybrids of human T and B lymphoblastoid cell lines (LCL). The T-LCL CEMR.3 expresses no HLA class II antigens. It expresses little total HLA class I antigen and no HLA-B antigens. The B-LCL 721.174 is a radiation-induced variant immunoselected for loss of class II antigen expression. In addition to showing a deletion of all HLA-DR and DQ structural genes, 721.174 expresses no HLA-B antigens and a decreased level of HLA-A antigen compared with the parental cell line. A hybrid of 721.174 and CEMR.3 expresses class II antigens encoded by CEMR.3. Increased expression of HLA class I antigens encoded by both 721.174 and CEMR.3 was also observed. Specifically, the previously undetectable HLA-B5 and HLA-Bw6 antigens encoded by 721.174 and CEMR.3, respectively, were present on the hybrid. Increased expression of the HLA-A2 antigen encoded by 721.174 was also observed. An immunoselected variant of the hybrid lacking both CEMR.3-derived copies of chromosome 6 lost expression of the HLA-B5 antigen encoded by 721.174 and expressed a decreased amount of HLA-A2. From these data, we infer that two complementary trans-acting factors mediate enhanced expression of HLA class I antigens in the hybrid. One of these factors is provided by a gene located on chromosome 6, derived from CEMR.3. The second factor, introduced by 721.174, is the gene previously postulated to induce expression of CEMR.3-encoded class I antigens in hybrids of CEMR.3 with B-LCL.


Structural Gene Parental Cell Antigen Expression Lymphoblastoid Cell Line Parental Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amos, D. B., Pool, P., and Grier, J.: HLA-A, HLA-B, HLA-C, and HLA-D. In N. R. Rose and H. Friedman (eds.): Manual of Clinical Immunology, pp. 978–986, American Society for Microbiology, Washington, 1980Google Scholar
  2. Arce-Gomez, B., Jones, E. A., Barnstable, C. J., Soloman, E., and Bodmer, W. F.: The genetic control of HLA-A and B antigens in somatic cell hybrids. Requirement for β 2 microglobulin. Tissue Antigens 11: 96–112, 1978Google Scholar
  3. Ayres, J. and Cresswell, P.: HLA-B specificities and w4, w6 specificities are on the same polypeptide. Eur. J. Immunol. 6: 794–799, 1976Google Scholar
  4. Benham, F. J., Quintero, M. A., and Goodfellow, P. N.: Human-mouse hybrids with an embryonal carcinoma phenotype continue to transcribe HLA-A, B, C. EMBO J. 2: 1963–1968, 1983Google Scholar
  5. Berger, A. E., Davis, J. E., and Cresswell, P.: Monoclonal antibody to HLA-A3. Hybridoma 1: 87–90, 1982Google Scholar
  6. Berggard, I. and Beam, A. G.: Isolation and properties of a low molecular weight β 2-globulin occurring in human biological fluids. J. Biol. Chem. 243: 4095–4103, 1968Google Scholar
  7. Billing, R. and Lucero, K.: A monoclonal antibody against an epitope common to HLA-B locus antigens. Hum. Immunol. 4: 351–357, 1982Google Scholar
  8. Bodmer, W. F.: Nomenclature for factors of the HLA-system 1984. Hum. Immunol. 11: 117–125, 1984Google Scholar
  9. Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., and Bodmer, W. F.: Monoclonal antibodies for analysis of the HLA system. Immunol. Rev. 47: 3–61, 1979Google Scholar
  10. Das, J. K., Lawrance, S. K., and Weissman, S. M.: Structure and nucleotide sequence of the heavy chain of HLA-DR. Proc. Natl. Acad. Sci. U.S.A. 80: 3543–3547, 1983Google Scholar
  11. DeMars, R., Chang, C. C., and Rudersdorf, R. A.: Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. Hum. Immunol. 8: 129–139, 1983Google Scholar
  12. DeMars, R.: Mutations that dissect the D-region of a human B-lymphoblastoid cell line. Dis. Markers 2, in press, 1984Google Scholar
  13. DeMars, R., Chang, C. C., Shaw, S., Reitnauer, P. J., and Sondel, P. M.: Homozygous deletions that simultaneously eliminate expressions of Class I and Class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of Class II antigens. Hum. Immunol. 11: 77–97, 1984Google Scholar
  14. Fellous, M., Nit, V., Wallach, D., Merlin, G., Rubinstein, M., and Revel, M.: Interferon dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc. Natl. Acad. Sci. U.S.A. 79: 3082–3086, 1982Google Scholar
  15. Foley, G. E., Lazarus, H., Sidney, F., Uzman, B. G., Boone, B. A., and McCarthy, R. E.: Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522–529, 1965Google Scholar
  16. Gladstone, P. and Pious, D.: Identification of a trans-acting function regulating HLA-DR expression in a DR-negative B cell variant. Somatic Cell Genet. 6: 285–289, 1980Google Scholar
  17. Hansen, G., Rubin, B., Sorensen, S. F., and Svejgaard, A.: Importance of HLA-D antigens for the cooperation between human monocytes and T lymphocytes. Eur. J. Immunol. 8: 520–525, 1978Google Scholar
  18. Haynes, B. F., Eisenbarth, G. S., and Fauci, A. S.: Human lymphocyte antigens: Production of a monoclonal antibody that defines functional thymus derived lymphocyte subsets. Proc. Natl. Acad. Sci. U.S.A. 76: 5829–5833, 1979Google Scholar
  19. Haynes, B. F., Reisner, E. G., Helmer, M. E., Strominger, J. L., and Eisenbarth, G. S.: Description of a monoclonal antibody defining an HLA allotypic determinant that includes specificities within the B5 cross reacting group. Hum. Immunol. 4: 273–285, 1982Google Scholar
  20. Heron, I., Hokland, M., and Berg, K.: Enhanced expression of β 2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc. Natl. Acad. Sci. U.S.A. 75: 6215–6219, 1978Google Scholar
  21. Howell, D. N. and Cresswell, P.: Expression of T-lymphoblast-encoded HLA-DR antigens on human T-B lymphoblast hybrids. Immunogenetics 17: 411–425, 1983Google Scholar
  22. Howell, D. N., Berger, A. E., and Cresswell, P.: Human T-B lymphoblast hybrids express HLA-DR specificities not expressed by either parent. Immunogenetics 15: 199–206, 1982Google Scholar
  23. Howell, D. N., Hartzman, R. J., and Cresswell, P.: Expression of T-lymphoblast-encoded HLA-DR, MT, and SB antigens on human T-B lymphoblast hybrids. Hum. Immunol. 8: 167–175, 1983Google Scholar
  24. Howell, D. N., Kostyu, D. D., Ting, J. P. Y., and Cresswell, P.: Expression of Class I histocompatibility antigens on human T-B hybrids. Somatic Cell Molec. Genet. 10: 217–224, 1984Google Scholar
  25. Johnson, J. P., Meo, T., Riethmuller, G., Schendel, D. J., and Wank, R.: Direct demonstration of an HLADR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3. J. Exp. Med. 156: 104–111, 1982Google Scholar
  26. Jones, E. A., Goodfellow, P. N., Bodmer, J. G., and Bodmer, W. F.: Serological identification of HLA-A-linked human “Ia-type” antigens. Nature 256: 650–652, 1975Google Scholar
  27. Kavathas, P., Bach, F. H., and DeMars, R.: Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. U.S.A. 77: 4251–4255, 1980Google Scholar
  28. Klein, G., Terasaki, P., Billing, R., Honig, R., Jondal, M., Rosen, A., Zeuthen, J., and Clements, G.: Somatic cell hybrids between human lymphoma lines. III. Surface markers. Int. J. Cancer 19: 66–76, 1977Google Scholar
  29. Klein, G., Zeuthen, J., Eriksson, I., Terasaki, P., Bernoco, M., Rosen, A., Masucci, G., Povey, S., and Ber, R.: Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). J. Natl. Cancer Inst. 64: 725–738, 1980Google Scholar
  30. Long, E. O., Mach, B., and Accolla, R. S.: Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA Class II gene family. Immunogenetics 19: 349–353, 1984Google Scholar
  31. Loosmore, S., Gladstone, P., Pious, D., Jerry, L. M., and Tamaoki, T.: Control of HLA-DR antigen expression at the pretranslational level: Comparison of an HLA-DR-positive B lymphoblastoid cell line and its HLA-DR-negative variant. Immunogenetics 15: 139–150, 1982Google Scholar
  32. McMichael, A. J., Ting, A., Zweerink, H. J., and Askonas, B. A.: HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature 270: 524–526, 1977Google Scholar
  33. Mears, J. G., Ramirez, F., Leibowitz, D., and Bank, A.: Organization of human δ and β-globin genes in cellular DNA and the presence of intragenic inserts. Cell 15: 15–23, 1978Google Scholar
  34. Muller, C., Ziegler, A., Muller, G., Schunter, F., and Wernet, P.: Monoclonal antibody (Tu48) defining alloantigenic Class I determinants specific for HLA-Bw4 and HLA-A w23, -Aw24, as well as -Aw32. Hum. Immunol. 5: 269–281, 1982Google Scholar
  35. Parham, P.: Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate. Immunogenetics 18: 1–16, 1983Google Scholar
  36. Pober, J. S., Collins, T., Gimbrone, M. A., Jr., Cotran, R. S., Gitlin, J. D., Fiers, W., Clayberger, C., Krensky, A. M., Burakoff, S. J., and Reiss, C. J.: Lymphocytes recognize human vascular endothelial and dermal fibroblast la antigens induced by recombinant immune interferon. Nature 305: 726–729, 1983Google Scholar
  37. Radka, S. F., Kostyu, D. D., and Amos, D. B.: A monoclonal antibody directed against the HLA-Bw6 epitope. J. Immunol. 128: 2804–2806, 1982Google Scholar
  38. Radka, S. F., Amos, D. B., Quackenbush, L. J., and Cresswell, P.: HLA-DR-7-specific monoclonal antibodies and a chimpanzee anti-DR7 serum detect different epitopes on the same molecule. Immunogeneties 19: 63–76, 1984aGoogle Scholar
  39. Radka, S. F., Machamer, C. E., and Cresswell, P.: Analysis of monoclonal antibodies reactive with human Class II beta chains by two-dimensional electrophoresis and western blotting. Hum. Immunol. 10: 177–188, 1984bGoogle Scholar
  40. Rodey, G. E., Luehrman, L. K., and Thomas, D. W.: In vitro primary immunization of human peripheral blood lymphocytes to KLH: Evidence for HLA-D region restriction. J. Immunol. 123: 2250–2254, 1979Google Scholar
  41. Southern, E. M.: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98: 503–517, 1975Google Scholar
  42. Springer, T. A., Strominger, J. L., and Mann, D.: Partial purification of detergent-soluble HL-A antigen and its cleavage by papain. Proc. Natl. Acad. Sci. U.S.A. 71: 1539–1543, 1974Google Scholar
  43. Strominger, J. L., Englehard, V. H., Fuks, A., Guild, B. C., Hyafil, F., Kaufman, J. F., Korman, A. J., Kostyk, T. G., Krangel, M. S., Lancet, D., Lopez de Castro, J. A., Mann, D. L., Orr, H. T., Parham, P. R., Parker, K. C., Ploegh, H. L., Pober, J. S., Robb, R. J., and Strominger, J. L.: Biochemical analysis of products of the MHC. In B. Benacerraf and M. E. Dorf (eds.): The Role of the Major Histocompatibility Complex in Immunobiology, Garland Press, New York, 1981Google Scholar
  44. Whitehead, A. S., Colten, H. R., Chang, C. C., and DeMars, R.: Localization of the human MHC-linked complement genes between HLA-B and HLA-DR using HLA mutant cell lines. J. Immunol. 134: 641–643, 1985Google Scholar
  45. Ziegler, A., Uchanska-Ziegler, B., Zeuthen, J., and Wernet, P.: HLA antigen expression at the single cell level on a K562 × B cell hybrid: An analysis with monoclonal antibodies using bacterial binding assays. Somatic Cell Genet. 8: 775–789, 1982Google Scholar
  46. Zinkernagel, R. M. and Doherty, P. C.: H-2 compatibility requirement for T-cell mediated lysis of target cells infected with lymphocytec choriomeningitis virus. J. Exp. Med. 141: 1427–1436, 1975Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Russell D. Salter
    • 1
  • David N. Howell
    • 1
  • Peter Cresswell
    • 1
  1. 1.Division of ImmunologyDuke University Medical CenterDurham

Personalised recommendations